Clinical Trials Directory

Trials / Completed

CompletedNCT03183102

The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.

Detailed description

This pilot study will begin to address whether gut microbiota change with estrogen suppression. Specifically, the investigators will test whether gut microbial diversity and abundance change in response to estrogen suppression and consumption of dietary flaxseed. To test this possibility the investigators will recruit premenopausal women (age 20-40 years old)and collect fecal samples before and after 1 month of estrogen suppression with GnRH agonist. The investigators will analyze the gut microbiota in response to estrogen loss and whether this differs with the consumption of flaxseed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFlaxseed2 months of dietary flaxseed supplementation

Timeline

Start date
2017-10-01
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2017-06-09
Last updated
2024-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03183102. Inclusion in this directory is not an endorsement.